Quinoline derivatives as antagonists of leukotriene D4, compositions containing the same and processes for their preparation
申请人:RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC.
公开号:EP0348155A1
公开(公告)日:1989-12-27
This invention relates to quinolinyl compounds of the general formula:
and the use of these compounds as pharmacological agents which are lipoxygenase inhibitors and/or leukotriene antagonists possessing anti-inflammatory and anti-allergic properties and their pharmaceutical compositions and processes for this preparation.
Quinoline derivatives as antagonists of leukotriene d4, compositions containing the same and processes for their preparation
申请人:Aventis Holdings Inc.
公开号:EP0784052B1
公开(公告)日:2004-09-01
US4920131A
申请人:——
公开号:US4920131A
公开(公告)日:1990-04-24
[EN] QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4
申请人:RORER INTERNATIONAL (OVERSEAS) INC.
公开号:WO1989012628A1
公开(公告)日:1989-12-28
(EN) This invention relates to quinolinyl compounds of general formula (I), and the use of these compounds as pharmacological agents which are lipoxygenase inhibitors and/or leukotriene antagonists possessing anti-inflammatory and anti-allergic properties and their pharmaceutical compositions and processes for this preparation.(FR) Cette invention concerne des composés de quinolinyle de la formule générale (I), ainsi que l'emploi de ces composés en tant qu'agents pharmacologiques inhibiteurs de lipoxygénase et/ou antagonistes de leukotriène possédant des propriétés anti-inflammatoires et anti-allergiques. Elle concerne également leurs compositions pharmaceutiques et des procédés de préparation.